SBI Life Insurance Company Limited (NSE:SBILIFE)
1,845.00
-7.70 (-0.42%)
Oct 24, 2025, 3:29 PM IST
NSE:SBILIFE Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Premiums & Annuity Revenue | 907,151 | 840,598 | 805,871 | 665,810 | 584,323 | 497,683 | Upgrade |
Total Interest & Dividend Income | -6,731 | 188,258 | 167,409 | 146,750 | 117,732 | 102,659 | Upgrade |
Gain (Loss) on Sale of Investments | 123,922 | 123,922 | 98,662 | -6,317 | 126,937 | 220,744 | Upgrade |
Other Revenue | 16,516 | 16,422 | 248,547 | 155.85 | 174.16 | 194.16 | Upgrade |
| 1,040,858 | 1,169,200 | 1,320,488 | 806,398 | 829,166 | 821,280 | Upgrade | |
Revenue Growth (YoY) | -30.76% | -11.46% | 63.75% | -2.75% | 0.96% | 87.74% | Upgrade |
Policy Benefits | 908,029 | 1,046,020 | 1,215,388 | 714,397 | 752,530 | 756,455 | Upgrade |
Policy Acquisition & Underwriting Costs | 40,616 | 37,388 | 32,553 | 30,625 | 21,583 | 17,788 | Upgrade |
Depreciation & Amortization | - | - | - | - | 1.38 | 2.07 | Upgrade |
Selling, General & Administrative | 43,613 | 43,560 | 38,791 | 32,621 | 28,501 | 23,046 | Upgrade |
Provision for Bad Debts | 11.7 | 11.8 | 25.5 | 9.33 | 305.15 | -0.75 | Upgrade |
Other Operating Expenses | 18,689 | 15,172 | 12,866 | 9,590 | 9,804 | 7,508 | Upgrade |
Total Operating Expenses | 1,013,237 | 1,142,150 | 1,299,619 | 787,239 | 812,197 | 804,797 | Upgrade |
Operating Income | 27,621 | 27,051 | 20,869 | 19,159 | 16,969 | 16,483 | Upgrade |
Interest Expense | -114.4 | -114.4 | -91.3 | -100.83 | -100.15 | -83.19 | Upgrade |
Other Non Operating Income (Expenses) | -0.1 | -0.1 | -0.2 | -0 | - | - | Upgrade |
EBT Excluding Unusual Items | 27,506 | 26,936 | 20,778 | 19,059 | 16,869 | 16,400 | Upgrade |
Other Unusual Items | -10 | -10 | - | - | - | - | Upgrade |
Pretax Income | 26,821 | 26,926 | 20,778 | 19,059 | 16,869 | 16,400 | Upgrade |
Income Tax Expense | 2,288 | 2,793 | 1,840 | 1,853 | 1,809 | 1,842 | Upgrade |
Net Income | 24,533 | 24,133 | 18,938 | 17,206 | 15,060 | 14,558 | Upgrade |
Net Income to Common | 24,533 | 24,133 | 18,938 | 17,206 | 15,060 | 14,558 | Upgrade |
Net Income Growth | 12.46% | 27.43% | 10.07% | 14.25% | 3.45% | 2.37% | Upgrade |
Shares Outstanding (Basic) | 1,002 | 1,002 | 1,001 | 1,001 | 1,000 | 1,000 | Upgrade |
Shares Outstanding (Diluted) | 1,003 | 1,003 | 1,002 | 1,001 | 1,001 | 1,000 | Upgrade |
Shares Change (YoY) | 0.06% | 0.08% | 0.05% | 0.04% | 0.06% | 0.00% | Upgrade |
EPS (Basic) | 24.48 | 24.09 | 18.92 | 17.19 | 15.06 | 14.56 | Upgrade |
EPS (Diluted) | 24.46 | 24.07 | 18.90 | 17.18 | 15.04 | 14.55 | Upgrade |
EPS Growth | 12.41% | 27.36% | 10.01% | 14.23% | 3.37% | 2.32% | Upgrade |
Free Cash Flow | 322,679 | 254,405 | 290,075 | 285,928 | 217,961 | 237,731 | Upgrade |
Free Cash Flow Per Share | 321.69 | 253.73 | 289.52 | 285.52 | 217.74 | 237.63 | Upgrade |
Dividend Per Share | - | 2.700 | 2.700 | 2.500 | 2.000 | 2.500 | Upgrade |
Dividend Growth | - | - | 8.00% | 25.00% | -20.00% | - | Upgrade |
Operating Margin | 2.65% | 2.31% | 1.58% | 2.38% | 2.05% | 2.01% | Upgrade |
Profit Margin | 2.36% | 2.06% | 1.43% | 2.13% | 1.82% | 1.77% | Upgrade |
Free Cash Flow Margin | 31.00% | 21.76% | 21.97% | 35.46% | 26.29% | 28.95% | Upgrade |
EBITDA | 28,361 | 27,798 | 21,632 | 19,837 | 17,718 | 17,477 | Upgrade |
EBITDA Margin | 2.73% | 2.38% | 1.64% | 2.46% | 2.14% | 2.13% | Upgrade |
D&A For EBITDA | 739.8 | 747.3 | 762.3 | 677.91 | 748.96 | 993.98 | Upgrade |
EBIT | 27,621 | 27,051 | 20,869 | 19,159 | 16,969 | 16,483 | Upgrade |
EBIT Margin | 2.65% | 2.31% | 1.58% | 2.38% | 2.05% | 2.01% | Upgrade |
Effective Tax Rate | 8.53% | 10.37% | 8.86% | 9.72% | 10.72% | 11.23% | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.